0001654954-22-009833.txt : 20220719 0001654954-22-009833.hdr.sgml : 20220719 20220719161601 ACCESSION NUMBER: 0001654954-22-009833 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20220719 ITEM INFORMATION: Completion of Acquisition or Disposition of Assets ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220719 DATE AS OF CHANGE: 20220719 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AEHR TEST SYSTEMS CENTRAL INDEX KEY: 0001040470 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] IRS NUMBER: 942424084 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22893 FILM NUMBER: 221091734 BUSINESS ADDRESS: STREET 1: 400 KATO TERRACE CITY: FREMONT STATE: CA ZIP: 94539 BUSINESS PHONE: 5106239400 MAIL ADDRESS: STREET 1: 400 KATO TERRACE CITY: FREMONT STATE: CA ZIP: 94539 8-K 1 aehr_8k.htm FORM 8-K aehr_8k.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

 

July 19, 2022

 

AEHR TEST SYSTEMS

(Exact name of registrant as specified in its charter)

 

California

 

000-22893

 

94-2424084

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

  

400 KATO TERRACE, FREMONT, CA 94539

(Address of principal executive offices, including zip code)

 

510-623-9400

(Registrant’s telephone number, including area code)

 

 N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

AEHR

The NASDAQ Capital Market

 

 

 

 

 

Item 2.02.  Results of Operations and Financial Condition.

 

On July 19, 2022, Aehr Test Systems, or the Company, issued a press release announcing the Company’s financial results for its fourth quarter and fiscal year ended May 31, 2022.  A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information in this Form 8-K, including the exhibit attached hereto, are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as amended, or the Exchange Act, or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01.  Financial Statements and Exhibits.

 

(d)  Exhibits.

 

Exhibit No.

 

Description

99.1 

 

Press Release of Aehr Test Systems dated July 19, 2022 entitled “Aehr Reports Record Revenue for Fiscal 2022 Fourth Quarter and Full Year Driven by Demand for Semiconductor Wafer Test and Burn-in for Electric Vehicles.”

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Aehr Test Systems

(Registrant)

    
Date: July 19, 2022By:/s/ Kenneth B. Spink

 

 

Kenneth B. Spink

Vice President of Finance and

Chief Financial Officer

 
   
    

 

 

3

 

 

 

EX-99.1 2 aehr_ex991.htm PRESS RELEASE aehr_ex991.htm

 

EXHIBIT 99.1

 

 

FOR IMMEDIATE RELEASE              

 

Contacts:

 

Aehr Test Systems

 

MKR Investor Relations Inc.

 

Ken Spink

 

Todd Kehrli or Jim Byers

 

Chief Financial Officer

 

Analyst/Investor Contact

 

(510) 623-9400 x309

 

(213) 277-5550

 

 

 

aehr@mkr-group.com

 

 

Aehr Reports Record Revenue for Fiscal 2022 Fourth Quarter and Full Year Driven by Demand for Semiconductor Wafer Test and Burn-in for Electric Vehicles

 

Fremont, CA (July 19, 2022) – Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced financial results for its fiscal 2022 fourth quarter and full year ended May 31, 2022.

 

Fiscal Fourth Quarter Financial Results:

 

 

·

Net sales were $20.3 million, up 166% from $7.6 million in the fourth quarter of fiscal 2021.

 

 

 

 

·

GAAP net income was $5.8 million, or $0.20 per diluted share, compared to GAAP net income of $567,000, or $0.02 per diluted share, in the fourth quarter of fiscal 2021.

 

 

 

 

·

Non-GAAP net income was $6.5 million, or $0.23 per diluted share, which excludes the impact of stock-based compensation, compared to non-GAAP net income of $930,000, or $0.04 per diluted share, in the fourth quarter of fiscal 2021.

 

 

 

 

·

Bookings were $4.4 million for the quarter ended May 31, 2022.

 

 

 

 

·

Backlog as of May 31, 2022 was $11.1 million. Effective backlog, which includes all orders since the end of the fourth quarter, is over $25.5 million.

 

 

 

 

·

Total cash and cash equivalents as of May 31, 2022 were $31.5 million, up from $4.6 million at May 31, 2021.

 

Fiscal Year Financial Results:

 

 

·

Net sales were $50.8 million, up 206% from $16.6 million in fiscal 2021.

 

 

 

 

·

GAAP net income was $9.5 million, or $0.34 per diluted share, compared to a GAAP net loss of $2.0 million, or $0.09 per diluted share, in fiscal 2021.

 

 

 

 

·

Non-GAAP net income was $11.7 million, or $0.42 per diluted share, compared to a non-GAAP net loss of $3.2 million, or $0.13 per diluted share, in fiscal 2021.

 

 

 

 

Aehr Test Systems Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results

July 19, 2022

Page 2 of 7

 

An explanation of the use of non-GAAP financial measures and a reconciliation of Aehr’s non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the accompanying tables.

 

Gayn Erickson, President and CEO of Aehr Test Systems, commented:

 

“We are pleased to report very strong growth for fiscal 2022, with a record annual revenue of $50.8 million, and record bookings of $60.2 million. Importantly, we are seeing the significant leverage in our operating model to our bottom line, as evidenced by the strong profit for the fiscal year.

 

“Our strong bookings and revenue growth in fiscal 2022 were driven by the demand for our wafer level test and burn-in solutions, particularly for wafer level stress and stabilization of silicon carbide devices for use directly in the electric vehicle market. The silicon carbide market for electric vehicles and its supporting infrastructure requirements are growing at a tremendous rate, with Canaccord Genuity estimating that wafer capacity will increase from 150,000 6-inch wafers in 2021 to over four million 6-inch equivalent wafers in 2030 to meet the electric vehicle market alone.

 

“Our lead customer for silicon carbide wafer level burn-in made significant investments in their silicon carbide production throughout this past fiscal year. Today, we are excited to announce we received $12.8 million in orders from them for multiple FOX-XP™ systems, a FOX™ high volume production WaferPak Aligner, and a small number of FOX WaferPaks to meet their increased production capacity needs for silicon carbide-based power semiconductors for the electric vehicle market. We expect significant subsequent orders for WaferPaks needed for the system orders announced today. These FOX systems, WaferPaks, and the WaferPak Aligner are expected to ship by the end of our fiscal third quarter ending February 28, 2023.

 

“Aehr Test provides a highly unique and cost-effective solution for applying stress testing across every device on an entire wafer before they are singulated and put into packages or multi-chip modules. This allows our customers to burn-in every single device at a lower cost than they could in any other form due to our ability to contact thousands of devices on a single wafer and test 18 wafers in a single system with our FOX-XP multi-wafer test and burn-in system and proprietary FOX full wafer contact WaferPaks.

 

“We are currently engaged with most other current and future silicon carbide suppliers. The major silicon carbide companies expect that most electric vehicle traction inverters will move to multi-chip modules. As such, they have told us that they must move to wafer level stress and burn-in to remove the inherent failures before they put the devices into multi-die modules to meet their cost, yield, and reliability goals of these modules. Aehr’s unique, low cost, multi-wafer level test and burn-in solution provides the test electronics and device contactor technology that enables contact to 100% of devices on a single wafer, and the handling and alignment equipment to provide a total turnkey single vendor solution to meet the needed critical test and stress requirements.

 

“Our benchmarks and evaluations with prospective new silicon carbide customers continue with very good momentum. We have recently completed a wafer stress testing of yet another of the current large suppliers of silicon carbide with excellent results. They have told us that the FOX platform is the only solution that can scale to meet the production capacity needed to address their silicon carbide device growth, particularly for electric vehicle applications. This is in addition to our previously announced engagement with another large silicon carbide supplier with whom we have been working closely over the last year to correlate and qualify the FOX system to displace their current production reliability screening test and burn-in systems. The results of that benchmark also met a key milestone this last quarter and we believe that we will successfully complete their correlation process over the coming months, which will allow them to move forward with our FOX-XP solution. We expect both customers to implement the FOX platform solution into their manufacturing production flow.

 

 

 

 

Aehr Test Systems Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results

July 19, 2022

Page 3 of 7

 

“In addition to the benchmarks with these two large silicon carbide companies, we have been approached by several more silicon carbide suppliers to evaluate our FOX-XP systems to meet their production needs for traction inverters and on-board charges for electric vehicles, and for other applications such as electric commuter train engine controllers, photovoltaic power conversion, and other industrial applications.

 

“As a result of all these positive evaluations, we believe that we will receive orders from at least several new silicon carbide customers and begin shipping systems to meet their production capacity by the end of our current fiscal year that ends May 31, 2023. There is a significant industry ramp needed to expand silicon carbide production to meet the forecasted needs of these electric vehicles over the next few years and through the end of the decade and beyond.  

 

“We are very encouraged by the positive momentum we are seeing with current and prospective customers and anticipate multiple new customers will begin placing orders and taking shipments over the next few years to meet the enormous demand of silicon carbide devices used in the electric vehicle market over the next decade. If current and/or new customers increase their forecasts and/or decide to pull in orders, we have significant upside capacity to meet their needs. This provides us with the confidence that we can meet a significant upside in revenue shipments if the customer demand pulls in.”

 

Fiscal 2023 Financial Guidance:

 

For the fiscal year ending May 31, 2023, Aehr expects total revenue to be at least $60 million to $70 million, with strong profit margins similar to last fiscal year. Aehr also expects bookings to grow faster than revenues in fiscal 2023 as the ramp in demand for silicon carbide in electric vehicles increases exponentially throughout the decade. 

 

Management Conference Call and Webcast

 

Aehr Test Systems will host a conference call and webcast today at 5:00 p.m. Eastern (2:00 p.m. PT) to discuss its fiscal 2022 fourth quarter and full year operating results. To access the live call, dial +1 877-270-2148 (US and Canada) or +1 412-902-6510 (International) and ask to join the Aehr Test Systems earnings call. In addition, a live and archived webcast of the conference call will be available over the Internet at www.aehr.com in the Investor Relations section and may also be accessed by clicking here. A replay of the conference call will also be available via telephone beginning approximately two hours after conclusion of the call and will remain available for one week. To access the call replay, dial +1 877-344-7529 or +1 412-317-0088 (International) and enter replay passcode: 2181375.

 

About Aehr Test Systems

 

Headquartered in Fremont, California, Aehr Test Systems is a worldwide provider of test systems for burning-in and testing logic, optical and memory integrated circuits and has installed over 2,500 systems worldwide. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr Test products in package, wafer level, and singulated die/module level test. Aehr Test has developed and introduced several innovative products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The ABTS system is used in production and qualification testing of packaged parts for both lower power and higher power logic devices as well as all common types of memory devices. The FOX-XP and FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems used for burn-in and functional test of complex devices, such as leading-edge silicon carbide-based power semiconductors, memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices. The FOX-CP system is a new low-cost single-wafer compact test and reliability verification solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The WaferPak Contactor contains a unique full wafer probe card capable of testing wafers up to 300mm that enables IC manufacturers to perform test and burn-in of full wafers on Aehr Test FOX systems. The DiePak Carrier is a reusable, temporary package that enables IC manufacturers to perform cost-effective final test and burn-in of both bare die and modules. For more information, please visit Aehr Test Systems’ website at www.aehr.com.

 

 

 

 

Aehr Test Systems Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results

July 19, 2022

Page 4 of 7

 

Safe Harbor Statement

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Aehr’s future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “going to,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “sees,” or “continue,” or the negative of these words or other similar terms or expressions that concern Aehr’s expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, Aehr’s ability to generate bookings and revenue increases in the future, including the first quarter of fiscal 2023; future requirements and orders of Aehr’s new and existing customers; bookings forecasted for proprietary WaferPakTM and DiePak consumables across multiple market segments; the temporary nature of customer pushouts; shipping timelines for products and follow-on capacity orders; the growth of Aehr’s systems and consumables, including as a percentage of total sales; financial guidance for fiscal 2023, including related to revenue and profitability, and expectations regarding fiscal 2023; Aehr’s ability to expand its number of customers using its FOX-PTM solutions; the ability to secure potential customer engagements; expectations related to long-term demand for Aehr’s productions and  the attractiveness of key markets; the belief that Aehr will be stronger after the current worldwide COVID-19 pandemic, including expectations related to greater production, more customers, more applications, and higher value products. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Aehr’s recent 10-K, 10-Q and other reports filed from time to time with the Securities and Exchange Commission. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.

 

–      Financial Tables to Follow

 

 

 

 

Aehr Test Systems Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results

July 19, 2022

Page 5 of 7

AEHR TEST SYSTEMS AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(in thousands, except per share data)

(unaudited)

 

Three Months Ended

Year Ended

May 31,

Feb 28,

May 31,

May 31,

May 31,

2022

2022

2021

2022

2021

Net sales

$ 20,289 $ 15,283 $ 7,638 $ 50,829 $ 16,600

Cost of sales

9,821 8,886 4,104 27,164 10,568

Gross profit

10,468 6,397 3,534 23,665 6,032

Operating expenses:

Selling, general and administrative

2,993 2,612 1,904 10,047 6,562

Research and development

1,655 1,529 1,029 5,818 3,652

Total operating expenses

4,648 4,141 2,933 15,865 10,214

Income (loss) from operations

5,820 2,256 601 7,800 (4,182 )

Interest income (expense), net

22 1 (11 ) 13 (46 )

Income from forgiveness of PPP loan

- - - 1,698 -

Net gain from dissolution of Aehr Test Systems Japan

- - - - 2,186

Other (expense) income, net

(38 ) 10 (23 ) 30 (162 )

Income (loss) before income tax (expense) benefit

5,804 2,267 567 9,541 (2,204 )

Income tax (expense) benefit

(10 ) (24 ) - (91 ) 177

Net income (loss)

$ 5,794 $ 2,243 $ 567 $ 9,450 $ (2,027 )

Net income (loss) per share

Basic

$ 0.21 $ 0.08 $ 0.02 $ 0.36 $ (0.09 )

Diluted

$ 0.20 $ 0.08 $ 0.02 $ 0.34 $ (0.09 )

Shares used in per share calculations:

Basic

27,003 26,871 23,659 26,014 23,457

Diluted

28,568 28,854 23,916 27,774 23,457

 

- more -

 

 

Aehr Test Systems Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results

July 19, 2022

Page 6 of 7

AEHR TEST SYSTEMS AND SUBSIDIARIES

Reconciliation of GAAP and Non-GAAP Results

(in thousands, except per share data)

(unaudited)

 

Three Months Ended

Year Ended

May 31,

Feb 28,

May 31,

May 31,

May 31,

2022

2022

2021

2022

2021

GAAP net income (loss)

$ 5,794 $ 2,243 $ 567 $ 9,450 $ (2,027 )

Stock-based compensation expense

737 880 303 2,923 1,101

Excess and obsolesence provision

(16 ) 1,026 60 1,031 176

Income from forgiveness of PPP loan

- - - (1,698 ) -

Income from disolution of Aehr Test Systems Japan

- - - - (2,401 )

Non-GAAP net income (loss)

$ 6,515 $ 4,149 $ 930 $ 11,706 $ (3,151 )

GAAP net income (loss) per diluted share

$ 0.20 $ 0.08 $ 0.02 $ 0.34 $ (0.09 )

Non-GAAP net income (loss) per diluted share

$ 0.23 $ 0.14 $ 0.04 $ 0.42 $ (0.13 )

Shares used in GAAP and non-GAAP diluted shares calculation

28,568 28,854 23,916 27,774 23,457

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP net income (loss) is a non-GAAP measure and should not be considered a replacement for GAAP results. Non-GAAP net income (loss) is a financial measure the Company uses to evaluate the underlying results and operating performance of the business. The limitation of this measure is that it excludes items that impact the Company's current period net income (loss). This limitation is best addressed by using this measure in combination with net income (loss) (the most directly comparable GAAP financial measure). These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies.

 

We believe these measures enhance investors’ ability to review the company’s business from the same perspective as the Company’s management and facilitate comparisons of this period’s results with prior periods.

 

- more -

 

 

Aehr Test Systems Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results

July 19, 2022

Page 7 of 7

AEHR TEST SYSTEMS AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(in thousands, except per share data)

(unaudited)

May 31,

February 28,

May 31,

2022

2022

2021

ASSETS

Current assets:

Cash and cash equivalents

$ 31,484 $ 32,020 $ 4,582

Accounts receivable, net

12,859 8,543 5,202

Inventories

15,051 14,152 8,849

Prepaid expenses and other

613 559 551

Total current assets

60,007 55,274 19,184

Property and equipment, net

1,203 776 677

Operating lease right-of-use assets

917 1,091 1,606

Other assets

201 214 198

Total assets

$ 62,328 $ 57,355 $ 21,665

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:

Accounts payable

$ 4,195 $ 3,307 $ 2,893

Accrued expenses

3,610 2,535 2,163

Operating lease liabilities, short-term

794 778 737

Customer deposits and deferred revenue, short-term

2,415 6,197 189

Line of credit

- - 1,400

Current portion of long-term debt

- - 1,679

Total current liabilities

11,014 12,817 9,061

Operating lease liabilities, long-term

212 415 1,007

Deferred revenue, long-term

69 90 99

Other liabilities

44 45 49

Total liabilities

11,339 13,367 10,216

Total shareholders' equity

50,989 43,988 11,449

Total liabilities and shareholders' equity

$ 62,328 $ 57,355 $ 21,665

 

# # #

 

 

EX-101.SCH 3 aehr-20220719.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 aehr-20220719_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Emerging Growth Company Document Period End Date Entity Incorporation State Country Code Entity Tax Identification Number Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Entity Address Address Line 1 Entity File Number Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Security 12b Title Trading Symbol Security Exchange Name EX-101.CAL 5 aehr-20220719_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 aehr-20220719_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 aehr-20220719_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE GRAPHIC 8 aehr_ex991img5.jpg begin 644 aehr_ex991img5.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# 4$! 0$ P4$! 0&!04&" T(" <' M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_ MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @("#_P 1" J /$# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#[+KY^_:>^ M);>!/AFVAZ;<&/6]?W6T+(V##!_RU?VX.P?[V?X:]VNKJWLK.:]NIDAMX%,D MLCG"HH&23^%?EQ\8?B!<_$KXGZGXB+.+!6^SZ?$?^65NGW/H6Y<^[&@#G=#T MSQ9XFOI+'P_;ZCJ=Q'"T[Q6Q=V6-?O-]*TO OCS7/ OCO2?%5G<32FRE#20M M(=LT9X=#_O+G^=?9O[)7PW/ACX=R>,M1@\O4O$(5X0R_-':C[G_?9^?Z;*^: M?VC_ (;M\/?BW=26<.S1=:W7UE@?+&2?WD?_ %O_'66@#]&-%UBP\0:#8ZY MI_:LDDA_9XU62*1T<75M\R-@_ZT5YC^QY\2_/T^Z^ M&6JW'[RWW7FEESU0M^]B'T8[Q_O/Z5Z7^UG_ ,FYZM_U]VO_ *-% 'Y]:3#X MBUS5;?2='%]?7]RVR&WA=F=V]A79?\*A^-W_ $)/B7_OQ)7+>#_%5]X(\9:; MXJTN&":]TZ4RPI< M&3@CY@K ]_6O=/^&T/BA_T _#/_ (#3?_'J /-/^%0_ M&[_H2?$O_?B2NX^%_P /?BAX?\;RZOXB\,ZUI^F0:3J7FW%U$ZQINLYE7)/^ MT16G_P -H?%#_H!^&?\ P&F_^/5Z3\,?CQXN^+&C^/-)\166E6\5GX?N;B,V M4;HQ;;MYW.W'S4 ?%/\ :%__ ,_T_P#W\:OUJ\#%F^'/AIF)9CI=MDG_ *Y+ M7Y$U[CIW[4/Q@TO3+73+'6+);:TA2"(&PB.U$7 [>@H _2>OEG]M*XFM_AYX M9:"5XV.IMRC8_P"635X-_P -9?&K_H.6'_@OB_PKD?'WQF\>?$S2K73?%E_; M7%M:3?:(A%;)$0^-O4>QH E^#UY>3?$&99+R9E_L;56^:1O^?":O._[0U#_G M^N/^_K5WOP8_Y*'/_P!@75?_ $@FKS:@#N%\#_%62-63PAXKD1QD%;"Y(8?] M\TG_ @OQ8_Z$WQ;_P""^Y_^)K[WTG]HCX,VVAZ?;S>.[998K>-''V:XX(49 M_@J[_P -)?!+_H?K;_P&N/\ XB@#\X/MWB30M6*->ZGIE];-@@R20RQ'^:FO MT _9C^(&M>/OA7Q61G/<\L,^PKX^_: \8:#XX^, MFH:]X:E,U@8(81<&-D\YD3!;#<^W/]VOIG]C+3+VV^%6N:E-"R07NI_N2P^^ M$C4%A[9./P-*6PT6]>\+^(7\3ZC)'I$SI)=2,C#&""QP:SO^$2\2?] 6X_2M M+Q!)XL'BC4U5M6\L74GE[!+MQDXQM_AK-\[Q=_STUC_R+7P%>E1]K+W9'ZQA M<3B8T(*,X[+O_F-_X1/Q-_T [C]*7_A$_$W_ $ [C]*7S_&'_/36/_(M'G>, M/^>NL?\ D6L/94?Y9?U\CL^M8S_GY#\?\Q/^$3\3?] .X_2C_A$_$W_0#N/T MI?.\8?\ /76/_(M'G>,/^>NL?^1:/94?Y9?U\@^M8S_GY#\?\Q/^$3\3?] . MX_2C_A$_$W_0#N/TI?.\8?\ /76/_(M'G>,/^>NL?^1:/94?Y9?U\@^M8S_G MY#\?\Q/^$3\3?] .X_2C_A$_$W_0#N/TI?.\8?\ /76/_(M'G>,/^>NL?^1: M/94?Y9?U\@^M8S_GY#\?\QO_ B7B;_H"7'Z44[SO&'_ #UUC_R+11[*E_+( M/K6,_P"?D/Q_S+/[7/Q*_P"$?\%1> ]+N,:GKB[[K8>8K0'I_P #88^BO7P? M#!-.VV&-Y& SA5S7V'X__9YU_P"('Q U;Q;J7Q0\.+)>S$QQY9A#$!A$'/\ M"N/YUZI\"?A3HGPCTC5I;KQ%INJZM?2*)KN%P$CA7[BW\6:K%#$BQHB6Z !1T ^2L/Q3XZ^)/CBTM[/Q5JFH:M#;/ MYD*S0#Y&QCC:M?J1_;VA_P#0:L?_ )3_&G2ZIIUO'%+)J%M''*,QEYE4./] MGUH _)?PIXDU+P?XNTKQ+H\FR]TZ<3Q^C8ZJ?9AD'V-?<7Q_\4:9XS_9$?Q3 MI,FZSU%K.9%W9*'S1N0_[2MD'Z5Q7C3]E.'Q-X[UO6_"?C31['3+N0W?V5E+ MFWW^\,Z;\2=$OO&5NESH$,^Z\B>'S59-I_@[\XKZN_X6-^QQ_T M*MA_X(W_ /B:XNW_ &,]=O0S6?Q"T.X5/O>3&[X_*G7'[&.O6:"2\^(&B6Z$ MX!EC= ?SH [+_A8W[''_ $*MA_X(W_\ B:V-#^(O[/\ =VFN:%\-M*AT[7-4 MTF\A5H=+:#S52W>0JS8Z83->70_L>:I+X]=B\:Z1J,<5I=VY2U1F(,UK+"K?F^?PH ^,*_0SPS^S'\']4\&Z+JE] MH%TUS>6,$\I%_,N7= Q_B]37CG_#&^N?;/L/_"PM"^U_\\?+??TS]WKTK['\ M/W>DZ)X6TG2)]69C7*LK36\D(;D M]B^?^ US8_9 U)HWD7XE>'F1>K -M7/XT 8%O^R+\6+JUANH7T3RYD5TW7K= M",_W*BO;?V/;6UO=PW7V6)(7>%PRY514G]K:9 M]I^R_P!HVWVC?Y?E>&-<\ ^,+GP_X@M(X=3L&4O&=LJ'* MA@?0J017W_\ LU^/+OQU\(C+?VUK;W&E7;Z?MM(EBC=%1'5MB\+]_'''%<'\ M:_@#-\2/B==>)K?QQHVE!X(H6MKD_.K(N.>:])^ ?PSNOA;X)U/2KK7++6?M MEZ;I9[,'8O[M$Q_X[2EL4<;X@\8>)(_%&I0IJKJL5S(JJ%7Y0"<+]VL__A-O M$W/_ !.9/^^(_P#XFM[7?'FOQ>)+^WC^RB."YDC3=#D[58BLW_A87B+_ *=/ M^_%?"5I+VDO>E_7S/U##4I.C!^QB]%U_X!2_X37Q-_T&)/\ OF/_ .)H_P"$ MU\3?]!B3_OF/_P")J]_PL+Q'_>M/^_%+_P +"\2>MI_WXK'FC_S\E_7S.KV$ M_P#GQ#[_ /@%#_A-?$W_ $&)/^^8_P#XFC_A-?$W_08D_P"^8_\ XFK_ /PL M+Q)ZVG_?BC_A87B3UM/^_%'-'_GY+^OF'L)_\^(??_P"A_PFOB;_ *#$G_?, M?_Q-'_":^)O^@Q)_WS'_ /$U?_X6%XD];3_OQ1_PL+Q)ZVG_ 'XHYH_\_)?U M\P]A/_GQ#[_^ 4/^$U\3?]!B3_OF/_XFC_A-?$W_ $&)/^^8_P#XFK__ L+ MQ)ZVG_?BC_A87B3UM/\ OQ1S1_Y^2_KYA["?_/B'W_\ *'_ FOB;_H,2?] M\Q__ !-%7?\ A87B3_IT_P"_%%'-'_GY+^OF'L)_\^(??_P#S#]I/X.> ?AK MX2T&_P#"NERVDU[J'V>8R74DN4V%OXC76?'+X/>!?AO\!-;U+PEIWC)EF\:O$[_*.63SOE/MVK1\ M;>#;?4OB]IT>FZ;X=\5V5MH5G!'X=RD,VX/NKR/\ MLW3O^?"V_P"_2_X5U/QZL[.VTOP%-;VL,,LGAS3M[QQA6;_1UZD=: .MT'0] M#T/XX^%](U[X;MX5&M++IXBT?Q MY%,)08F\P9=MN'VL-Z^HJQ\;O@[X!\$_ M$GX<:+X?TV:VLM>O?)OD>Y=RZ>="O!8_+P[=*XW]EVVM[CX\:/\ :+>.;RU> M1-Z!MK;#\PST/O7T5^T1##)\7?A%YD*/_P 3+^)0?^6]O0!ZYX!^%O@OX9Q7 M\7@_39+)=0*-<"2XDEW%,[?ODX^\:^?_ -I#P_-X@^-/A812Z1K7EV&&\.7^ MJ?8FF^>0[PVY/E..H;/[NOKNOC7]M"UM=FAWWV:+[5L\OS]@W[=S_+NZX]J M. U33M+\"^-?"&L:U\+4\)(FI1LMQH7B9;MW*LIY1FE^[_P'=DC->D?%;PWK M7[/WC"3XM?#9K>#2-5?'/P MU;7EO%<0&]3,*^T?VJ423X#MYB!_^)A;_>&?[U 'GWA_X2R:3\#/ M%?Q#\7Z_ OC7Q-ISS'5+R7$=E'-C"[UZ,^5#,.F=HXSN\N\._#Z;_A!X)G^$ M7AWQ*/+8MJ\'B]8GF'S?.$\[:K#_ '>W2OLBXM+6Z^ #VUS;13P?\(Z/W4B! ME_X]O0\5^6$W_'Q+_O'^= 'VM\$?AO\ #'XN?"2U;6-&U23^PKR>TC2YU%F\ MK?LE(0H$^3YNA7KNKD?V;O@[X!^)'A[Q'>>*M*ENIK#4%@@*74D6U-N: M]\_9GM;:W^!6E_9[>*'S)&D?8@7>V$^8XZGWKFOV2888O#'BWRXD3_B:#[J@ M?P4 ?.>D^'M.U3XI?$*.Y\,Z!K:6^L3*BZSKITSROWTOW,2)OSCGKMP/6MOQ MEH&DZ+\#_$KV?AGP_H=P]_8*1H^O-J9E3,V=X:1]@!VX]=U;L&_;M;C/7'M2>PUN=)KOBF&/Q-J2-X9TN0I<2 M+O:,EGVD\M[UG?\ "5P_]"KH_P#WX-6/$=O!_P )3J?[F/\ X^)/X1_>-9/V M>WY_<1_]\BOA:TZGM9>]^"/UK!X.A.C!RCT75E[_ (2J'_H5=(_[\FE_X2J' M_H5=(_[\FJ'V>W_YX1_]\BG?9[?_ )X1_P#?(KGYZO\ -^".OZAA_P"7\67? M^$JA_P"A5TC_ +\FC_A*H?\ H5=(_P"_)JE]GM_^>$?_ 'R*/L]O_P \(_\ MOD4^>I_-^"#ZAA_Y?Q9=_P"$JA_Z%72/^_)H_P"$JA_Z%72/^_)JE]GM_P#G MA'_WR*/L]O\ \\(_^^11SU/YOP0?4,/_ "_BR[_PE4/_ $*ND?\ ?DT?\)5# M_P!"KI'_ 'Y-4OL]O_SPC_[Y%'V>W_YX1_\ ?(HYZG\WX(/J&'_E_%ES_A*H C?^A5TC_OR:*I_9[?_GA'_P!\BBIYZO\ -^"#ZAA_Y?Q9_]D! end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Cover
Jul. 19, 2022
Cover [Abstract]  
Entity Registrant Name AEHR TEST SYSTEMS
Entity Central Index Key 0001040470
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company false
Document Period End Date Jul. 19, 2022
Entity Incorporation State Country Code CA
Entity Tax Identification Number 94-2424084
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Address Address Line 1 400 KATO TERRACE
Entity File Number 000-22893
Entity Address City Or Town FREMONT
Entity Address State Or Province CA
Entity Address Postal Zip Code 94539
City Area Code 510
Local Phone Number -623-9400
Security 12b Title Common Stock, par value $0.01 per share
Trading Symbol AEHR
Security Exchange Name NASDAQ
XML 10 aehr_8k_htm.xml IDEA: XBRL DOCUMENT 0001040470 2022-07-19 2022-07-19 iso4217:USD shares iso4217:USD shares 0001040470 false 8-K 2022-07-19 AEHR TEST SYSTEMS CA 000-22893 94-2424084 400 KATO TERRACE FREMONT CA 94539 510 -623-9400 false false false false false Common Stock, par value $0.01 per share AEHR NASDAQ EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 1 22 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://aehr.com/role/Cover Cover Cover 1 false false All Reports Book All Reports aehr_8k.htm aehr-20220719.xsd aehr-20220719_cal.xml aehr-20220719_def.xml aehr-20220719_lab.xml aehr-20220719_pre.xml aehr_ex991.htm http://xbrl.sec.gov/dei/2022 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "aehr_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "aehr-20220719_cal.xml" ] }, "definitionLink": { "local": [ "aehr-20220719_def.xml" ] }, "inline": { "local": [ "aehr_8k.htm" ] }, "labelLink": { "local": [ "aehr-20220719_lab.xml" ] }, "presentationLink": { "local": [ "aehr-20220719_pre.xml" ] }, "schema": { "local": [ "aehr-20220719.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "aehr", "nsuri": "http://aehr.com/20220719", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "span", "strong", "p", "body", "html" ], "baseRef": "aehr_8k.htm", "contextRef": "From2022-07-19to2022-07-19", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://aehr.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "strong", "p", "body", "html" ], "baseRef": "aehr_8k.htm", "contextRef": "From2022-07-19to2022-07-19", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 17 0001654954-22-009833-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-22-009833-xbrl.zip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�"RWZQ95NOO/^]+5EXO6EWN)@ 7=9?D2 M(J?I\*0=N,/3_P=02P$"% ,4 " @O-4-E!FF88$ "#%@ $0 M @ $ 865H&UL4$L! A0#% @ (+S5/-#K/R2 @ 1 @ !4 M ( !P@8 &%E:'(M,C R,C W,3E?9&5F+GAM;%!+ 0(4 Q0 ( ""\U0* M>*-$#P8 '&UL4$L! A0#% @ (+S5%GN M+#"]#@ B54 L ( !@A0 &%E:')?.&LN:'1M4$L! A0# M% @ (+S5)!NQ%EG* ]!0" X ( !:", &%E:')? ?97@Y.3$N:'1M4$L%!@ ' < P $ /M+ $! end